ClinicalTrials.gg
Sign In

Paraplegia clinical trials

The registry lists 151 studies for Paraplegia across more than 10 countries. 36 are recruiting or about to start. 39 of them are mainly about Paraplegia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Paraplegia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
71
Recruiting
32
Status unknown
21
Terminated
11
Active, not recruiting
7
Withdrawn
4

Phase

Phase 2
21
Phase 1
15
Phase 3
10
Phase 4
2
Early Phase 1
1

Where

United States
64
France
24
United Kingdom
9
Switzerland
7
Germany
7
Spain
7

Who runs them

Wandercraft (8) · VA Office of Research and Development (7) · James J. Peters Veterans Affairs Medical Center (4) · ABLE Human Motion S.L. (4) · University Hospital, Montpellier (4) · University of Miami (3) · Institut National de la Santé Et de la Recherche Médicale, France (3) · University of Manitoba (3)

What is being tested here

Drugs under test in Paraplegia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Extended-release Galantamine Hydrobromide111
Galantamine111
Psilocybin101
Adezunap111
Exoenzyme C3, Clostridium botulinum012
Chenodeoxycholic Acid001
Resveratrol001
Atorvastatin001
Ursolic Acid001
Fenofibrate011

Coming up

5phase 3 studies under way
15studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 32 Paraplegia studies recruiting now, 15 (47%) set no upper age limit and 14 (44%) stop at 75 or younger. 6 (19%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (13%) take healthy volunteers.

Recruiting studies that take each age, of 32
AgeWomenMen
105 (16%)5 (16%)
1823 (72%)23 (72%)
3030 (94%)30 (94%)
4029 (91%)29 (91%)
5029 (91%)29 (91%)
6527 (84%)27 (84%)
7523 (72%)23 (72%)
8517 (53%)17 (53%)

Across all 151 studies, recruiting or not: 52% stop at 75 or younger and 34% at 65; 15% take children; 0% are for women only and 4% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Paraplegia studies take

Of 60 interventional studies with no phase under Paraplegia, half reached primary completion within 37 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase37 mo12–131 · 60 studies—40 mo23–131 · 44 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Stopped1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 151. Browse all 151 → or search them.